Tuesday, November 20, 2018 12:40:26 AM
So, there is no business reason for an RS, all evidence to date is completely contradictory to such a notion.
There have been zero claims to a negative long term outlook for AMFE.
Zero, i have asked 395 times now over the past year, and not a single time has anyone made a negative long term case backed by evidence.
Simple as that.
Real News:
https://www.otcmarkets.com/stock/AMFE/news
Real Results:
https://www.otcmarkets.com/stock/AMFE/disclosure
$$$$ AMFE $$$$
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM